410 related articles for article (PubMed ID: 31493470)
1. Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems.
Filippova J; Matveeva A; Zhuravlev E; Stepanov G
Biochimie; 2019 Dec; 167():49-60. PubMed ID: 31493470
[TBL] [Abstract][Full Text] [Related]
2. Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs.
Laustsen A; Bak RO
Methods Mol Biol; 2019; 1961():127-134. PubMed ID: 30912044
[TBL] [Abstract][Full Text] [Related]
3. A Single Transcript CRISPR-Cas9 System for Multiplex Genome Editing in Plants.
Tang X; Zhong Z; Ren Q; Liu B; Zhang Y
Methods Mol Biol; 2019; 1917():75-82. PubMed ID: 30610629
[TBL] [Abstract][Full Text] [Related]
4. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
[TBL] [Abstract][Full Text] [Related]
5. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
Basila M; Kelley ML; Smith AVB
PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
[TBL] [Abstract][Full Text] [Related]
6. "Split-and-Click" sgRNA.
Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
[TBL] [Abstract][Full Text] [Related]
7. Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.
Kundert K; Lucas JE; Watters KE; Fellmann C; Ng AH; Heineike BM; Fitzsimmons CM; Oakes BL; Qu J; Prasad N; Rosenberg OS; Savage DF; El-Samad H; Doudna JA; Kortemme T
Nat Commun; 2019 May; 10(1):2127. PubMed ID: 31073154
[TBL] [Abstract][Full Text] [Related]
8. Genome Editing Using CRISPR/Cas9 System in the Rice Blast Fungus.
Arazoe T
Methods Mol Biol; 2021; 2356():149-160. PubMed ID: 34236684
[TBL] [Abstract][Full Text] [Related]
9. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
Suresh B; Ramakrishna S; Kim H
Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
[TBL] [Abstract][Full Text] [Related]
10. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Wilbie D; Walther J; Mastrobattista E
Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
[TBL] [Abstract][Full Text] [Related]
11. High efficiency CRISPR/Cas9 genome editing system with an eliminable episomal sgRNA plasmid in Pichia pastoris.
Yang Y; Liu G; Chen X; Liu M; Zhan C; Liu X; Bai Z
Enzyme Microb Technol; 2020 Aug; 138():109556. PubMed ID: 32527526
[TBL] [Abstract][Full Text] [Related]
12. Versatile 3' Functionalization of CRISPR Single Guide RNA.
Palumbo CM; Gutierrez-Bujari JM; O'Geen H; Segal DJ; Beal PA
Chembiochem; 2020 Jun; 21(11):1633-1640. PubMed ID: 31943634
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.
Sahoo N; Cuello V; Udawant S; Litif C; Mustard JA; Keniry M
Methods Mol Biol; 2020; 2115():365-383. PubMed ID: 32006411
[TBL] [Abstract][Full Text] [Related]
14. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
Graf R; Li X; Chu VT; Rajewsky K
Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
[TBL] [Abstract][Full Text] [Related]
15. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
Hoellerbauer P; Kufeld M; Paddison PJ
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
[TBL] [Abstract][Full Text] [Related]
16. A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.
Nahar S; Sehgal P; Azhar M; Rai M; Singh A; Sivasubbu S; Chakraborty D; Maiti S
Chem Commun (Camb); 2018 Mar; 54(19):2377-2380. PubMed ID: 29450416
[TBL] [Abstract][Full Text] [Related]
17. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
[TBL] [Abstract][Full Text] [Related]
18. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
Bai B; Myklebust JH; Wälchli S
Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
[TBL] [Abstract][Full Text] [Related]
19. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
Shin HR; Kweon J; Kim Y
Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
[TBL] [Abstract][Full Text] [Related]
20. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
Zhang S; Shen J; Li D; Cheng Y
Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
